AI in Pharma R&D
Navigating efficiency, compliance and innovation in basic and preclinical (drug) development
- Update regulatory frameworks: EU AI Act, EMA/FDA principles
- AI-supported document creation (example: GLP Study Plans + Final Report)
- Project insights
- Officially certified: ISO 9001 + 21001
Online-Seminar
Ab
690,00 €
zzgl. MwSt.
Leistungen & Ablauf
Veranstaltung - 690,-€ zzgl. MwSt.
The registration fee includes downloadable materials, a certificate, access to the Learning Space, and technical support, including a pre-meeting.
Period:
From 09:00 am until 12:30 pm CET
You may dial in 30 minutes before the lecture starts
Buchungsdetails
Online-Seminar
Ab
690,00 €
zzgl. MwSt.
Leistungen & Ablauf
Veranstaltung - 690,-€ zzgl. MwSt.
The registration fee includes downloadable materials, a certificate, access to the Learning Space, and technical support, including a pre-meeting.
Period:
From 09:00 am until 12:30 pm CET
You may dial in 30 minutes before the lecture starts
AI in Pharma R&D: During the half-day seminar you will learn how to navigate compliance requirements due to regulatory frameworks, you will explore how structured content enables AI-supported document creation, and how to combine established scientific methods with AI to accelerate drug development in basic and preclinical research.
Your speakers
Timo Ahland
Boehringer Ingelheim Pharma GmbH & Co. KG,
Ingelheim am Rhein, GERMANY
Data Protection Officer for Germany and
Head of the European Data Protection Team
Timo Ahland studied law at Ruhr University Bochum…
Your speaker
Timo Ahland
Boehringer Ingelheim Pharma GmbH & Co. KG,
Ingelheim am Rhein, GERMANY
Data Protection Officer for Germany and
Head of the European Data Protection Team
Timo Ahland studied law at Ruhr University Bochum and the German University of Administrative Sciences in Speyer. He is admitted to the bar by the Koblenz Higher Regional Court.
Prior to his current role as Data Protection Officer, he spent six years as a corporate lawyer, specializing in advising the global corporate procurement and IT departments of the Boehringer Ingelheim Group.
Timo Ahland has served as the appointed in-house Data Protection Officer and external Data Protection Officer for the operating companies of the Boehringer Ingelheim Group in Germany (approx. 15,000 employees) and, together with his team supporting the Group Data Protection Officer, oversees the European region with a network of currently approx. 25 regional and local data protection officers and experts. He represents the company in data protection matters before numerous associations at the national level (BDI, VCI, BAVC, and vfa).
He regularly serves as a speaker at professional and continuing education events on data protection, with a focus on medical research and drug development.
Christian Mehrmann
cormeo GmbH,
Gütersloh, GERMANY
Director Solultion Portfolio
Christian Mehrmann is Director Solution Portfolio at cormeo, where he focuses on advancing pharma-tech solutions for regulated information…
Your speaker
Christian Mehrmann
cormeo GmbH,
Gütersloh, GERMANY
Director Solultion Portfolio
Christian Mehrmann is Director Solution Portfolio at cormeo, where he focuses on advancing pharma-tech solutions for regulated information management, including areas such as structured content authoring, ePI, and Track & Trace.
He brings over 15 years of experience at arvato Systems, where he held roles as Senior Product Manager and Senior Business Analyst, gaining deep expertise in product management, business development, and project management. Prior to that, he worked as Product and Business Development Manager at ROTE LISTE®.
He has further developed his expertise through certifications in Machine Learning and Python.
Dr. Irina Tihaa
d-fine GmbH,
Düsseldorf, GERMANY
Manager
Dr. Irina Tihaa is a at d-fine and drives AI and digital innovation projects for clients in the Pharma & Healthcare sector, focusing on user-centered…
Your speaker
Dr. Irina Tihaa
d-fine GmbH,
Düsseldorf, GERMANY
Manager
Dr. Irina Tihaa is a Manager at d-fine and drives AI and digital innovation projects for clients in the Pharma & Healthcare sector, focusing on user-centered application of both emerging and established technologies as well as end-to-end processes.
Before joining d-fine, Irina worked at Forschungszentrum Jülich and RWTH Aachen University.
What to Expect
- Overview about AI policy and regulatory frameworks
- Structured content as basis for AI-based document compilation - Use case: Preparation of a GLP Final Report based on content from the GLP Study Plan/Protocol
- Project insights: Combining established and innovative methods to elucidate mechanism-of-action pathways for intervention development
Who Should Attend
In case you're considering AI implementation, our new program provides essential insights for informed decision-making in preclinical research.
This course is designed for pharmaceutical R&D professionals, including project managers, scientific researchers and regulatory affairs specialists who want to stay current with AI developments in basic and preclinical (drug) development.
Objective of the Event
This seminar offers a timely opportunity to deepen your understanding of artificial intelligence (AI) as it reshapes preclinical drug development.
You, as professional in Pharma R&D, will gain practical knowledge of the latest regulatory frameworks, including the EU AI Act and the joint EMA/FDA principles published in January 2026, equipping you to navigate compliance requirements with confidence.
Furthermore, you will explore how structured content enables AI-supported document creation in regulated environments (use case: preparation of a GLP Final Report based on content from the GLP Study Plan/Protocol).
Through real-world project insights, you will learn how to strategically combine established scientific methods with AI and explainable AI (xAI) to uncover mechanisms of action and accelerate drug discovery.
Whether you are evaluating AI adoption or looking to optimise your current approach, this course provides the critical knowledge needed to stay competitive and compliant in a rapidly evolving field.
Your Benefit
Upon participation, you will
- learn about evolving compliance requirements and regulatory frameworks for AI-assisted pharmaceutical development.
- understand the importance of "data preparation" and the use of structured content.
- gain up-to-date knowledge on the latest AI applications and hybrid approaches in preclinical research.
- understand when AI solutions are optimal versus when traditional or combined methods deliver better results.
Programme
From 09:00 am until 12:30 pm CET
Timo Ahland
- Development and deployment of AI-based tools in public health
- Insight into the EU AI Act's risk-based approach and its intersection with existing regulations
- EMA/FDA principles for AI in medicine development (published January 14, 2026)
- Practical strategies for navigating compliance while advancing innovation
- Authority's expectations? (The topic will be addressed if significant details become available to the public by the time of the seminar.)
Christian Mehrmann
Chosen real-life example: SCA- and AI-assisted preparation of a GLP Final Report based on content from the GLP Study Plan/Protocol. The "questions" listed below will be discussed using the chosen use case.
- Why structure comes before AI OR Why document quality starts with structure
- AI as support in (regulatory) document creation
- Consistency, traceability and compliance by design
- Opportunities, limits and practical considerations
Dr Irina Tihaa
- Data first: How rigorous data preparation lays the foundation for meaningful analysis
- Choosing the right tools: Combining established methods, AI and xAI to understand pathways and mechanisms of protective drugs
- From insight to impact: Using interpretable data/results to reveal true modes of action and guide drug discovery
Welcome, introduction, expectations
Overview about AI policy and regulatory frameworks
Overview about AI policy and regulatory frameworks
Timo Ahland
- Development and deployment of AI-based tools in public health
- Insight into the EU AI Act's risk-based approach and its intersection with existing regulations
- EMA/FDA principles for AI in medicine development (published January 14, 2026)
- Practical strategies for navigating compliance while advancing innovation
- Authority's expectations? (The topic will be addressed if significant details become available to the public by the time of the seminar.)
Structured content as basis for AI-based document compilation (use case: Preparation of a GLP Final Report)
Structured content as basis for AI-based document compilation (use case: Preparation of a GLP Final Report)
Christian Mehrmann
Chosen real-life example: SCA- and AI-assisted preparation of a GLP Final Report based on content from the GLP Study Plan/Protocol. The "questions" listed below will be discussed using the chosen use case.
- Why structure comes before AI OR Why document quality starts with structure
- AI as support in (regulatory) document creation
- Consistency, traceability and compliance by design
- Opportunities, limits and practical considerations
Biobreak
Project insights: Combining established and innovative methods to elucidate mechanism-of-action pathways for intervention development
Project insights: Combining established and innovative methods to elucidate mechanism-of-action pathways for intervention development
Dr Irina Tihaa
- Data first: How rigorous data preparation lays the foundation for meaningful analysis
- Choosing the right tools: Combining established methods, AI and xAI to understand pathways and mechanisms of protective drugs
- From insight to impact: Using interpretable data/results to reveal true modes of action and guide drug discovery
Outstanding questions and final discussion
End of seminar
Downloads
Request the documents using our form.
Brochure
Qualifikationslehrgang_zum_Development_Expert_Biologics
Weitere Informationen
In-house seminars: Advanced training tailor-made
You are looking for this topic for several employees?
We offer the right solution at your site or in virtual format!
We also offer this seminar as an in-house seminar.
Take advantage of the proven concepts of our open seminars and bring your employees to the same level of knowledge quickly and easily.
We will be happy to send you a non-binding offer.
Free pre-meeting and technology check
You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.
The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.
Technical requirements
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
Access to and procedure for online events
Once you have registered for an event, we will send you the access information for your customer portal. Click here to log in to the customer portal using your email address and password. Please ensure you can access the customer portal before the day of the event.
All important or additional information and personal documents are available in your personalised customer portal. This is also where you start your online courses. If you do not have access to the customer portal yet, you can easily register here.
On the day of the event, you kick off your online training in the customer portal by clicking ‘Participate’ directly in the respective event. You will then be redirected to the Learning Space.
Learn more about our online events here.
Our Recommendations
GMP-/GDP-Auditor
Das "missing link" unter den Lehrgängen - wir schließen die Lücke und schulen Sie in unserem Zertifikatslehrgang zum GDP-Auditor!Sprache: Deutsch
Verunreinigungen in Arzneimitteln - Fokus Nitrosamine
Verunreinigungen in Arzneimitteln: Fokus Nitrosamine - So setzen Sie die behördlichen Forderungen pragmatisch und sicher um und werden Ihrer Verantwortung gerecht! Inklusive Praxisbeispielen,…Sprache: Deutsch
Projektmanagement im GxP-Bereich
Projektmanagement (PM) im GxP-Bereich - Projekte im regulierten Umfeld erfolgreich und effizient steuern!Sprache: Deutsch
Quality Specialist in Clinical Research
Der viertägige Online-Intensivlehrgang vermittelt Ihnen umfassendes Know-how im Qualitätsmanagement der Klinischen Forschung. Sie frischen Ihre Kenntnisse der Regularien auf, erhalten viele Tipps für…Sprache: Deutsch
CTD: requirements for non-clinical/clinical modules and eCTD-readiness
Non-clinical/clinical content in the dossier: Are you a beginner in the field and would like to feel confident working competently on modules 2, 4 and 5 in the future? Are you already an experienced…Sprache: Englisch
Further Information
In-house seminars
Our programmes are also available for in-house training. Just contact us!
Newsletter on trends and findings
Stay up to date - we regularly inform you about new regulatory and professional developments.
Our rating in 2025
More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.
Your Contact Person
We are happy to advise you personally and individually.
Dr. Birgit Wessels
Conference Manager
+49 6221 500-652
b.wessels@forum-institut.de